Peter S. Linsley
Virginia Mason Medical Center · 341 works · 72,866 citations · h-index 104
Top works
- Gene expression profiling predicts clinical outcome of breast cancer
- Microarray analysis shows that some microRNAs downregulate large numbers of target mRNAs
- CTLA-4 is a second receptor for the B cell activation antigen B7.
- CTLA-4 can function as a negative regulator of T cell activation
- Expression profiling reveals off-target gene regulation by RNAi
- Long-Term Survival of Xenogeneic Pancreatic Islet Grafts Induced by CTLA4lg
- T-cell antigen CD28 mediates adhesion with B cells by interacting with activation antigen B7/BB-1.
- Costimulation of antitumor immunity by the B7 counterreceptor for the T lymphocyte molecules CD28 and CTLA-4
- Immunosuppression in Vivo by a Soluble Form of the CTLA-4 T Cell Activation Molecule
- Experimental annotation of the human genome using microarray technology
- Role of the CD28 receptor in T-cell activation
- Genetics of gene expression surveyed in maize, mouse and man
- A microRNA component of the p53 tumour suppressor network
- T-cell activation by the CD28 ligand B7 is required for cardiac allograft rejection in vivo.
- The tissue distribution of the B7-2 costimulator in mice: abundant expression on dendritic cells in situ and during maturation in vitro.
- CTLA-4 and PD-1 Receptors Inhibit T-Cell Activation by Distinct Mechanisms
- Identification of an Alternative CTLA-4 Ligand Costimulatory for T Cell Activation
- Long-term acceptance of skin and cardiac allografts after blocking CD40 and CD28 pathways
- A large-scale RNAi screen in human cells identifies new components of the p53 pathway
- MAST: a flexible statistical framework for assessing transcriptional changes and characterizing heterogeneity in single-cell RNA sequencing data